US08659B1026
US08659B1026
Beta Bionics, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 951.07M EUR | 704.86M EUR | 446.51M EUR | 1.35B EUR |
Enterprise Value | 610.19M EUR | 667.06M EUR | 423.21M EUR | 1.33B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -7.58x | -- | -- | -- |
Price to Sales | 7.99x | 5.92x | 4.05x | 16.36x |
Price to Book | 3.09x | 2.75x | 1.65x | 4.7x |
EV/Revenue | 5.13x | 5.6x | 3.84x | 16.07x |
EV/EBITDA | -7.55x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -4.24% | -8.71% | -13.69% | -2.66% |